In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Fluidigm Corp.. Trade Record

NASDAQ:FLDM Fluidigm Corp. stock gains 45.23% Exit Mar 26, 2019 a Trade Record by priceseries

Trade Chart
Trade Chart FLDM Feb 8, 2019, priceSeries
About Fluidigm Corp.

Fluidigm Corporation creates, manufactures, and markets technologies and tools for life sciences research. It offers preparatory instruments, such as access array system, juno system, and callisto system; analytical instruments comprising biomark HD and EP1 system; integrated fluidic circuits (IFCs) consisting of access array, juno genotyping, dynamic array, digital array, flex six, and callisto IFCs; and assays and reagents, including delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. The company also provides C1 single-cell systems, polaris systems, C1 IFCs, polaris IFCs, helios/CyTOF 2 systems, maxpar reagents, imaging mass cytometer instruments and reagents, and laser ablation modules. It serves academic institutions; clinical research laboratories; biopharmaceutical, biotechnology, and agricultural biotechnology companies; and contract research organizations. Fluidigm Corporation distributes its systems through direct sales force and support organizations located in North America, Europe, and the Asia-Pacific, and through distributors or sales agents in various European, Latin American, Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was founded in 1999 and is headquartered in South San Francisco, California.

Trade Information
Trade Type
LONG
ReliabilityScore™
95.73
Entry Date
Feb 8, 2019
Entry Price
9.35
Sell Date
Mar 26, 2019
Sell Price
13.58
Net Gain
45.23%
Hold Time
31 Trading Days